Protagenic Therapeutics Inc logo

Protagenic Therapeutics Inc

NEW
NAS:PTIX (USA)  
$ 0.39 -0.029 (-7.01%) 11:08 PM EST
At Loss
P/B:
2.73
Enterprise V:
$ -2.05M
Volume:
4.70M
Avg Vol (2M):
7.70M
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
4.70M
At Loss
Avg Vol (2M):
7.70M

Business Description

Description
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.52
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2
Quick Ratio 2
Cash Ratio 1.95

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.4
Shareholder Yield % -69.97
Name Current Vs Industry Vs History
ROE % -331.89
ROA % -233.5
ROIC % -5816.33
ROC (Joel Greenblatt) % -5627.29
ROCE % -331.89

Financials (Next Earnings Date:2025-04-08 Est.)

PTIX's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:PTIX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Protagenic Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.27
Beta 1.29
3-Year Sharpe Ratio -0.85
3-Year Sortino Ratio -1.09
Volatility % 43.74
14-Day RSI 61.28
14-Day ATR ($) 0.070403
20-Day SMA ($) 0.271415
12-1 Month Momentum % -77.69
52-Week Range ($) 0.179 - 1.87
Shares Outstanding (Mil) 7.24

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Protagenic Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Protagenic Therapeutics Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Protagenic Therapeutics Inc Frequently Asked Questions

What is Protagenic Therapeutics Inc(PTIX)'s stock price today?
The current price of PTIX is $0.39. The 52 week high of PTIX is $1.87 and 52 week low is $0.18.
When is next earnings date of Protagenic Therapeutics Inc(PTIX)?
The next earnings date of Protagenic Therapeutics Inc(PTIX) is 2025-04-08 Est..
Does Protagenic Therapeutics Inc(PTIX) pay dividends? If so, how much?
Protagenic Therapeutics Inc(PTIX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1